相关实验视频
Updated: May 24, 2025

12:24
Helical Organization of Blood Coagulation Factor VIII on Lipid Nanotubes
Published on: June 3, 2014
12.2K
作为补充介导疾病治疗的治疗点的B因子
David Kavanagh1, Jonathan Barratt2, Anna Schubart3
1National Renal Complement Therapeutics Centre, Newcastle University, Newcastle-upon-Tyne, United Kingdom.
Frontiers in immunology
|March 3, 2025
概括
补充因子B对于先天免疫的替代途径至关重要. 抑制B因子通过阻断放大循环,为补充介导疾病提供了向治疗.
科学领域:
- 免疫学 免疫学 免疫学
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 补体系统是天生的免疫系统的关键组成部分,有三个启动途径:经典性,乳清性和替代性.
- 补体系统的调节失调与自身免疫和炎症性疾病有关.
- 已批准的补充抑制剂存在,但针对替代途径 (AP) 的疗法正在出现.
研究的目的:
- 概述补充因子B及其在AP中的作用.
- 讨论B因子抑制的治疗益处和风险.
- 描述当前和正在开发的B因子抑制剂.
主要方法:
- 审查关于补充系统的科学文献,特别是替代途径.
- 分析B因子在补充激活中的作用.
- 检查已批准和正在研究的B因子抑制剂.
主要成果:
- 补充因子B对于APC3和C5转化酶活性至关重要.
- 抑制B因子可以选择性地阻止AP放大循环和下游膜攻击复合体的形成.
- 这种有针对性的方法避免了对经典和莱克通路激活的干扰.
结论:
- 乙因子是过度激活AP的疾病的有吸引力的治疗点.
- 抑制B因子为管理补充介导炎症和自身免疫疾病提供了一种选择性策略.
- 几种B因子抑制剂正在临床开发中,表明有望用于向补充疗法.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
590
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
590
Extrinsic and Intrinsic Pathways of Hemostasis
4.7K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
4.7K
Clot Retraction and Fibrinolysis
3.3K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
3.3K
Antimicrobial Proteins
864
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
864
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.1K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.1K
Factors Affecting Protein-Drug Binding: Drug Interactions
85
Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
85

